Related Experiment Video
Updated: Dec 23, 2025

23:56
Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
Published on: October 31, 2010
17.0K
Non-AIDS defining cancers: a comprehensive update on diagnosis and management
M Ceccarelli1, E Venanzi Rullo, M A Marino
1Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy. gpellicano@unime.it.
European Review for Medical and Pharmacological Sciences
|April 25, 2020
Summary
People living with HIV (PLWH) face rising rates of non-AIDS defining cancers. This review updates knowledge on diagnosing and managing these cancers in PLWH, crucial for infectious disease specialists.
Area of Science:
- Oncology
- Infectious Diseases
- Public Health
Background:
- Combined antiretroviral therapy (cART) has improved outcomes for people living with HIV (PLWH).
- However, there is an increasing incidence of non-AIDS defining cancers in PLWH on cART.
- These include lung, breast, colorectal, prostate cancers, hepatocellular carcinoma, and Hodgkin's lymphoma.
Purpose of the Study:
- To provide an updated review of non-AIDS defining cancers in PLWH.
- To discuss the diagnosis and management strategies for these cancers.
- To explore potential future scenarios in cancer care for PLWH.
Main Methods:
- Literature review of recent studies and clinical information.
- Synthesis of current data on cancer incidence, diagnosis, and treatment in PLWH.
- Analysis of trends and future projections.
Main Results:
- Non-AIDS defining cancers are a growing concern in the PLWH population.
- Early suspicion and diagnosis are critical for effective management.
- Management requires a multidisciplinary approach tailored to PLWH.
Conclusions:
- Infectious disease specialists must be vigilant in suspecting and diagnosing non-AIDS defining cancers in PLWH.
- Updated knowledge and tailored management strategies are essential.
- Future research should focus on prevention and improved treatment outcomes.
More Related Videos
Related Concept Videos
Treatment Resistant Cancers
3.6K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.6K
Cancer Survival Analysis
586
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
586
Cancer Vaccines
871
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
871
Cancer Therapies
9.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.7K
Targeted Cancer Therapies
8.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.5K
Cancer-Critical Genes II: Tumor Suppressor Genes
9.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.3K

